Holen Sie sich die Stockscreener-App
26.41
1.05%
0.275
Handel nachbörslich:
24.12
-2.295
-8.69%
Schlusskurs vom Vortag:
$26.14
Offen:
$25.77
24-Stunden-Volumen:
17,170
Relative Volume:
0.47
Marktkapitalisierung:
$186.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.98M
KGV:
-20.05
EPS:
-1.3177
Netto-Cashflow:
$-3.85M
1W Leistung:
+8.44%
1M Leistung:
-3.28%
6M Leistung:
-20.79%
1J Leistung:
+2,392%
1-Tages-Spanne:
$25.77
$26.61
1-Wochen-Bereich:
$24.00
$26.83
52-Wochen-Spanne:
$0.94
$79.02
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Firmenname
Bright Minds Biosciences Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie DRUG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
26.41 | 172.55M | 0 | -4.98M | -3.85M | -1.3177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-13 | Eingeleitet | TD Cowen | Buy |
| 2025-05-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-01-23 | Eingeleitet | Piper Sandler | Overweight |
| 2025-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-26 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Bright Minds Biosciences Inc Aktie (DRUG) Neueste Nachrichten
Bright Minds Biosciences Inc. Stock Analysis and ForecastFree Investment Case Studies - jammulinksnews.com
What drives Bright Minds Biosciences Inc. stock priceFree Stock Movement Tracking - jammulinksnews.com
Why Bright Minds Biosciences Inc. stock attracts strong analyst attentionFree Stock Market Practical Discussion Forums - Newser
Is Bright Minds Biosciences Inc. a good long term investmentMarket-leading profit generation - jammulinksnews.com
How Bright Minds Biosciences Inc. stock performs during market volatilityVerified Chart Patterns - Newser
(DRUG) Investment Analysis and Advice - news.stocktradersdaily.com
What analysts say about Bright Minds Biosciences Inc. stockOutstanding capital growth - Autocar Professional
What drives TTAM stock priceHigh-yield investments - Jammu Links News
Can Bright Minds Biosciences Inc. stock recover from recent declineFree Top-Rated Stock Analysis - Newser
Does Bright Minds Biosciences Inc. stock pay reliable dividendsMoney Making Low Risk Plans - Newser
What makes Bright Minds Biosciences Inc. stock price move sharplyRisk Controlled Trading Ideas - Newser
Why TBCH stock attracts strong analyst attentionTop Momentum Stock Pick - Newser
How To Trade (DRUG) - news.stocktradersdaily.com
Cantor Fitzgerald Forecasts DRUG FY2025 Earnings - Defense World
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Given Consensus Rating of “Buy” by Analysts - Defense World
4,793 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Acquired by Bank of America Corp DE - Defense World
DRUG FY2025 EPS Forecast Raised by Cantor Fitzgerald - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) & SCYNEXIS (NASDAQ:SCYX) Head-To-Head Survey - Defense World
6,600 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Acquired by Jane Street Group LLC - Defense World
40,379 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Purchased by Millennium Management LLC - Defense World
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of “Buy” from Analysts - Defense World
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times
Bright Minds Showcases Revolutionary CNS Drug Portfolio at Major Jefferies Healthcare Conference - Stock Titan
HC Wainwright Issues Pessimistic Outlook for DRUG Earnings - Defense World
What is Chardan Capital’s Forecast for DRUG FY2025 Earnings? - Defense World
Chardan Capital Reiterates “Buy” Rating for Bright Minds Biosciences (NASDAQ:DRUG) - Defense World
Bright Minds Biosciences (DRUG) Receives Consistent 'Buy' Rating from Chardan Capital | DRUG Stock News - GuruFocus
Bright Minds (DRUG) Schedules Virtual R&D Day to Discuss Epileps - GuruFocus
Finanzdaten der Bright Minds Biosciences Inc-Aktie (DRUG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):